Penn State startup aims to improve treatment of hydrocephalus
Normal pressure hydrocephalus is a disease resulting from too much cerebrospinal fluid around the brain. NPH symptoms are often confused with Alzheimer’s disease but in many cases are reversible with the placement of a shunt. The HydroFix shunt developed by Penn State researchers is designed to mitigate the risks associated with the current shunts on the market and provide a durable treatment solution for NPH patients.Image: Penn State
Penn State startup aims to improve treatment of hydrocephalus
May 28, 2021
UNIVERSITY PARK, Pa. Normal pressure hydrocephalus (NPH) is a disease resulting from too much cerebrospinal fluid (CSF) around the brain and affects roughly 750,000 Americans, typically those over 65 years old. Symptoms are often confused with Alzheimer’s disease, but in many cases they are reversible with the placement of a shunt.
Dustin Ritter, who has macular dystrophy, has made a career out of his art and teaching others.
Social Sharing
Dustin Ritter, who has macular dystrophy, has made a career out of his art and teaching others
Posted: Jan 23, 2021 5:00 AM CT | Last Updated: January 23
Dustin Ritter, a portrait artist in Regina, has an eye condition that makes some tasks, such as reading a recipe, difficult. He uses drawing as an escape. (Heidi Atter/CBC)